CCM
KLRS

Coldstream Capital Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Coldstream Capital Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-208
Closed -$1.67K – 3524
2025
Q1 		$1.67K Buy
+208
New +$1.67K ﹤0.01% 3058